多发性硬化症患者使用奥克立珠单抗后出现的组织性肺炎：病例报告。

IF 0.7 Q4 RESPIRATORY SYSTEM

Tuberkuloz ve Toraks-Tuberculosis and Thorax Pub Date : 2023-03-01 DOI:10.5578/tt.20239913

Nurten Aysan, Gizem Köybaşı, Celal Satıcı, Mustafa Asım Demirkol, Burcu Arpınar Yiğitbaş, Ayşe Filiz Arpaçağ Koşar

{"title":"多发性硬化症患者使用奥克立珠单抗后出现的组织性肺炎：病例报告。","authors":"Nurten Aysan, Gizem Köybaşı, Celal Satıcı, Mustafa Asım Demirkol, Burcu Arpınar Yiğitbaş, Ayşe Filiz Arpaçağ Koşar","doi":"10.5578/tt.20239913","DOIUrl":null,"url":null,"abstract":"Ocrelizumab is an anti-CD20 monoclonal antibody used in the treatment of primary progressive and relapsing multiple sclerosis (MS). Although cases of organizing pneumonia have been reported in association with other antiCD20 agents such as rituximab, there is insufficient data in the literature on Ocrelizumab-associated lung involvement. Herein, we present a case of organizing pneumonia in a 37-year-old female patient with multiple sclerosis following Ocrelizumab use.","PeriodicalId":45521,"journal":{"name":"Tuberkuloz ve Toraks-Tuberculosis and Thorax","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10795250/pdf/","citationCount":"0","resultStr":"{\"title\":\"Organizing pneumonia following ocrelizumab use in a patient with multiple sclerosis: A case report.\",\"authors\":\"Nurten Aysan, Gizem Köybaşı, Celal Satıcı, Mustafa Asım Demirkol, Burcu Arpınar Yiğitbaş, Ayşe Filiz Arpaçağ Koşar\",\"doi\":\"10.5578/tt.20239913\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Ocrelizumab is an anti-CD20 monoclonal antibody used in the treatment of primary progressive and relapsing multiple sclerosis (MS). Although cases of organizing pneumonia have been reported in association with other antiCD20 agents such as rituximab, there is insufficient data in the literature on Ocrelizumab-associated lung involvement. Herein, we present a case of organizing pneumonia in a 37-year-old female patient with multiple sclerosis following Ocrelizumab use.\",\"PeriodicalId\":45521,\"journal\":{\"name\":\"Tuberkuloz ve Toraks-Tuberculosis and Thorax\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2023-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10795250/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Tuberkuloz ve Toraks-Tuberculosis and Thorax\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5578/tt.20239913\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tuberkuloz ve Toraks-Tuberculosis and Thorax","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5578/tt.20239913","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}

引用次数: 0

摘要

Ocrelizumab 是一种抗 CD20 单克隆抗体，用于治疗原发性进展性和复发性多发性硬化症（MS）。虽然已有与其他抗 CD20 药物（如利妥昔单抗）相关的组织化肺炎病例报道，但有关奥克立珠单抗肺部受累的文献数据并不充分。在此，我们介绍了一例 37 岁女性多发性硬化症患者在使用 Ocrelizumab 后出现组织性肺炎的病例。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Organizing pneumonia following ocrelizumab use in a patient with multiple sclerosis: A case report.

Ocrelizumab is an anti-CD20 monoclonal antibody used in the treatment of primary progressive and relapsing multiple sclerosis (MS). Although cases of organizing pneumonia have been reported in association with other antiCD20 agents such as rituximab, there is insufficient data in the literature on Ocrelizumab-associated lung involvement. Herein, we present a case of organizing pneumonia in a 37-year-old female patient with multiple sclerosis following Ocrelizumab use.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Tuberkuloz ve Toraks-Tuberculosis and Thorax RESPIRATORY SYSTEM-

CiteScore

1.50

自引率

9.10%

发文量